Maintenance of long-lived plasma cells and serological memory despite mature and memory B cell depletion during CD20 immunotherapy in mice

被引:288
作者
DiLillo, David J. [1 ]
Hamaguchi, Yasuhito [1 ]
Ueda, Yoshihiro [1 ]
Yang, Kaiyong [1 ]
Uchida, Junji [1 ]
Haas, Karen M. [1 ]
Kelsoe, Garnett [1 ]
Tedder, Thomas F. [1 ]
机构
[1] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA
关键词
D O I
10.4049/jimmunol.180.1.361
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD20 mAb-mediated B cell depletion is an effective treatment for B cell malignancies and some autoimmune diseases. However, the full effects of B cell depletion on natural, primary, and secondary Ab responses and the maintenance of Ag-specific serum Ig levels are largely unknown. The relationship between memory B cells, long-lived plasma cells, and long-lived Immoral immunity also remains controversial. To address the roles of B cell subsets in the longevity of Immoral responses, mature B cells were depleted in mice using CD20 mAb. Peritoneal B cell depletion reduced natural and Ag-induced IgM responses. Otherwise, CD20(+) B cell depletion prevented Immoral immune responses and class switching and depleted existing and adoptively transferred B cell memory. Nonetheless, B cell depletion did not affect serum Ig levels, Ag-specific Ab titers, or bone marrow Ab-secreting plasma cell numbers. Coblockade of LFA-1 and VLA-4 adhesion molecules temporarily depleted long-lived plasma cells from the bone marrow. CD20(+) B cell depletion plus LFA-1/VLA-4 mAb treatment significantly prolonged Ag-specific plasma cell depletion from the bone marrow, with a significant decrease in Ag-specific serum IgG. Collectively, these results support previous claims that bone marrow plasma cells are intrinsically long-lived. Furthermore, these studies now demonstrate that mature and memory B cells are not required for maintaining bone marrow plasma cell numbers, but are required for repopulation of plasma cell-deficient bone marrow. Thereby, depleting mature and memory B cells does not have a dramatic negative effect on preexisting Ab levels.
引用
收藏
页码:361 / 371
页数:11
相关论文
共 62 条
  • [1] BENNER R, 1981, CLIN EXP IMMUNOL, V46, P1
  • [2] Maintenance of serological memory by polyclonal activation of human memory B cells
    Bernasconi, NL
    Traggiai, E
    Lanzavecchia, A
    [J]. SCIENCE, 2002, 298 (5601) : 2199 - 2202
  • [3] MEMORY B-CELLS AT SUCCESSIVE STAGES OF DIFFERENTIATION - EXPRESSION OF SURFACE IGD AND CAPACITY FOR SELF RENEWAL
    BLACK, SJ
    TOKUHISA, T
    HERZENBERG, LA
    HERZENBERG, LA
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1980, 10 (11) : 846 - 851
  • [4] Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis
    Cambridge, G
    Leandro, MJ
    Edwards, JCW
    Ehrenstein, MR
    Salden, M
    Bodman-Smith, M
    Webster, ADB
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (08): : 2146 - 2154
  • [5] Dal Porto JM, 1998, J IMMUNOL, V161, P5373
  • [6] Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin's lymphoma:: Safety and efficacy of re-treatment
    Davis, TA
    Grillo-López, AJ
    White, CA
    McLaughlin, P
    Czuczman, MS
    Link, BK
    Maloney, DG
    Weaver, RL
    Rosenberg, J
    Levy, R
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (17) : 3135 - 3143
  • [7] Efficacy of selective B cell blockade in the treatment of rheumatoid arthritis - Evidence for a pathogenetic role of B cells
    De Vita, S
    Zaja, F
    Sacco, S
    De Candia, A
    Fanin, R
    Ferraccioli, G
    [J]. ARTHRITIS AND RHEUMATISM, 2002, 46 (08): : 2029 - 2033
  • [8] Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes
    Edwards, JCW
    Cambridge, G
    [J]. RHEUMATOLOGY, 2001, 40 (02) : 205 - 211
  • [9] ABNORMAL B-LYMPHOCYTE DEVELOPMENT, ACTIVATION, AND DIFFERENTIATION IN MICE THAT LACK OR OVEREXPRESS THE CD19 SIGNAL-TRANSDUCTION MOLECULE
    ENGEL, P
    ZHOU, LJ
    ORD, DC
    SATO, S
    KOLLER, B
    TEDDER, TF
    [J]. IMMUNITY, 1995, 3 (01) : 39 - 50
  • [10] Hapten-induced primary and memory humoral responses are inhibited by the infusion of anti-CD20 monoclonal antibody (IDEC-C2B8, Rituximab)
    Gonzalez-Stawinski, GV
    Yu, PB
    Love, SD
    Parker, W
    Davis, RD
    [J]. CLINICAL IMMUNOLOGY, 2001, 98 (02) : 175 - 179